Skip to main content
PHAR logo
PHAR
(NASDAQ)
Pharming Group N.V.
$16.62-- (--)
Loading... - Market loading

Pharming Group (PHAR) Stock Price & Financial Analysis

Pharming Group Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$15.74 - $16.94
52-Week High$21.34
52-Week Low$7.50
Open$16.94
Volume41.58K
Average Volume (3M)41.58K
Market Cap1.11B
Shares Outstanding66.90M
P/E Ratio (TTM)2963.41
Price to Sales (P/S)3.12
Price to Book (P/B)4.28
EV/EBITDA24.55
Revenue (TTM)362.27M
Net Income (TTM)382.00K
Free Cash Flow (TTM)52.71M
EPS (TTM)$0.01
Profit Margin0.11%
Operating Margin8.56%
Return on Equity (ROE)0.14%
Debt to Equity0.37
50-Day MA$16.73
200-Day MA$14.81
52-Week Change96.22%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Pharming Group

What is the current stock price for PHAR?

As of the latest trading session, PHAR stock trades at $16.62. The 52-week range is $7.50–$21.34, with a day range of $15.74–$16.94.

What is the P/E ratio for PHAR?

Pharming Group's trailing P/E ratio is 2963.4, meaning investors pay $2963.4 for every $1 of annual earnings. Pharming Group operates in the Healthcare sector.

Does PHAR pay dividends?

Pharming Group does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for PHAR?

Based on 2 analysts, the consensus for PHAR is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of PHAR?

Pharming Group's market capitalization is $1.11B, classifying it as a small-cap company. Pharming Group operates in the Healthcare sector within the Biotechnology industry.